| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Bruton tyrosine kinase | 0.464 | 0.808 | 1.00 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 2013 | 2016 | ||||||||
|
inositol polyphosphate-4-phosphatase type II B | 0.573 | 0.577 | 0.55 |
|
disease | 0.380 | None | 1.000 | 0 | 0 | 2010 | 2017 | ||||||||
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2 | 0.568 | 0.692 | 1.00 |
|
disease | 0.310 | None | 1.000 | 0 | 0 | 2007 | 2007 | ||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
disease | 0.700 | None | 0.961 | 0 | 0 | 2007 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 0 | 0 | 2007 | 2020 | ||||||||
|
nuclear receptor corepressor 1 | 0.597 | 0.731 | 1.00 |
|
disease | 0.550 | None | 1.000 | 0 | 0 | 2006 | 2016 | ||||||||
|
3-phosphoinositide dependent protein kinase 1 | 0.588 | 0.808 | 0.98 |
|
disease | 0.550 | None | 1.000 | 0 | 0 | 2005 | 2019 | ||||||||
|
polybromo 1 | 0.566 | 0.615 | 1.00 |
|
disease | 0.340 | None | 1.000 | 0 | 0 | 2005 | 2017 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 2004 | 2020 | ||||||||
|
caspase 8 | 0.404 | 0.923 | 3.7E-06 |
|
disease | 0.700 | None | 0.980 | 0 | 0 | 2004 | 2019 | ||||||||
|
notch receptor 2 | 0.441 | 0.808 | 1.00 |
|
disease | 0.680 | None | 1.000 | 0 | 0 | 2004 | 2019 | ||||||||
|
T-box transcription factor 3 | 0.525 | 0.769 | 0.99 |
|
disease | 0.600 | None | 0.929 | 0 | 0 | 2004 | 2017 | ||||||||
|
forkhead box A1 | 0.522 | 0.731 | 0.22 |
|
disease | 0.600 | None | 0.986 | 0 | 0 | 2004 | 2019 | ||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 2004 | 2020 | ||||||||
|
BRCA1 interacting protein C-terminal helicase 1 | 0.507 | 0.731 | 6.2E-17 |
|
disease | 0.700 | None | 0.950 | 0 | 0 | 2003 | 2020 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.700 | None | 0.952 | 0 | 0 | 2001 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.700 | None | 0.987 | 0 | 0 | 2001 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.992 | 0 | 0 | 2001 | 2020 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.400 | None | 0.940 | 0 | 0 | 1999 | 2020 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.700 | None | 0.992 | 0 | 0 | 1999 | 2020 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 1998 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase 4 | 0.559 | 0.692 | 1.00 |
|
disease | 0.360 | None | 1.000 | 0 | 0 | 1998 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase kinase 13 | 0.743 | 0.192 | 0.80 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 1997 | 2017 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.700 | None | 0.966 | 0 | 0 | 1997 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.600 | None | 0.965 | 0 | 0 | 1996 | 2019 |